TABLE 2—

Regression Table for Difference-in-Differences Model With State-Level Fixed Effects for Number of Prescriptions: United States, 2011–2016

	Opioids, b (95% CI)	Buprenorphine, b (95% CI)	Methadone, b (95% CI)	Naltrexone, b (95% CI)
Post (1 = postexpansion; 0 = preexpansion)	5 985.31 (3 700.49, 8 270.13)	214.07 (15.79, 412.35)	−8.37 (–60.54, 43.80)	36.44 (21.98, 50.90)
Post × expanded	−1 619.79 (–4 541.75, 1 302.16)	996.67 (744.71, 1 248.64)	−56.30 (–120.32, 7.73)	38.99 (20.69, 57.28)
(Constant)	12 226.25 (11 291.60, 13 160.91)	760.71 (679.29, 842.14)	335.69 (315.56, 355.82)	48.87 (43.06, 54.67)

Note. CI = confidence interval. All prescribing rates are number of prescriptions reimbursed by Medicaid per 100 000 Medicaid enrollees.